Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
This Perspective presents the outcomes of an interdisciplinary international workshop that addressed the implications of the WHO classification change of pituitary adenoma to neuroendocrine tumours. The authors propose that a comprehensive classification system be developed integrating clinical, genetic, biochemical, radiological, pathological and molecular information for all anterior pituitary neoplasms.
This Review examines the origins of marrow adipocytes and their function under normal or pathological conditions. Regulation of bone marrow adipose tissue by nutrient status is considered, as well as the interactions between bone marrow adipose tissue, haematopoietic cells of the bone marrow and the bone.
Endocrine-disrupting chemicals (EDCs) contribute to human disease, disability and economic damage. This Review outlines a set of evidence-based policy actions to manage, minimize or eliminate the use of EDCs, alongside a number of specific challenges and potential recommendations.
This Review discusses challenges in the management of Cushing disease in adults and provides information to help with planning an integrated and individualized approach for each patient.
Funcke et al. shed light on the management of leptin replacement therapy in monogenic obesity by identifying two LEP variants with antagonistic functional effects. Their groundbreaking study emphasizes the urgent need for in-depth understanding of the genetic factors involved in obesity to pave the way for tailored interventions.
This Review discusses the physiological and neurological mechanisms that drive altered eating behaviours in pregnancy, including food cravings, food aversions and changes in sensory perception, and the implications for the long-term health of the gestational parent and offspring.
For patients with osteoporosis, the long-term use of bone-specific pharmacological therapies, including antiresorptive and/or osteoanabolic approaches, has raised concerns around adverse effects or potential rebound phenomena after treatment discontinuation. This Review outlines clinical data on long-term and sequential treatment for osteoporosis.
A new study convincingly demonstrates a deficiency of pituitary oxytocin secretion in patients with vasopressin deficiency. Neuropsychological evaluations of these patients indicate increased anxiety and reduced prosocial behaviours, thereby characterizing the phenotype of the first documented disorder of oxytocin deficiency in humans.
